Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
D000914:Antibodies, Viral / Q000032:analysis / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D016027:Heart Transplantation; D006801:Humans; D007111:Immunity, Cellular; D007372:Interferons / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use
D000914:Antibodies, Viral; D014765:Viral Vaccines; D007372:Interferons; D014740:Vidarabine